Guildford, UK, 24 September 2015: ReNeuron Group plc (the “Company”) (AIM: RENE), a leading UK-based stem cell therapy company, is pleased to provide a trading update ahead of today’s Annual General Meeting.
Guildford, UK, 24 September 2015: ReNeuron Group plc (the “Company”) (AIM: RENE), a leading UK-based stem cell therapy company, is pleased to provide a trading update ahead of today’s Annual General Meeting.